Problems and challenges in the use of immunomodulating agents. A general introduction.
D000276:Adjuvants, Immunologic / Q000276:immunology*; D000744:Anemia, Hemolytic, Autoimmune / Q000188:drug therapy; D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D003524:Cyclosporins / Q000494:pharmacology; D003602:Cytotoxicity, Immunologic / Q000187:drug effects; D004306:Dose-Response Relationship, Immunologic; D004334:Drug Administration Schedule; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000139:chemically induced; D007166:Immunosuppressive Agents / Q000276:immunology*; D007694:Killer Cells, Natural / Q000187:drug effects; D007978:Levamisole / Q000627:therapeutic use; D008264:Macrophages / Q000187:drug effects; D051379:Mice; D008934:Mitogens / Q000276:immunology; D009374:Neoplasms, Experimental / Q000188:drug therapy; D013154:Spleen / Q000187:drug effects; D013601:T-Lymphocytes / Q000187:drug effects
D000276:Adjuvants, Immunologic; D003524:Cyclosporins; D007166:Immunosuppressive Agents; D008934:Mitogens; D007978:Levamisole